AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • North Carolina
This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on , 2018, by and between Tim Albury (“Executive”) and Liquidia Technologies, Inc., a Delaware corporation (the “Company”). Each of the Company and Executive is a “Party” and, collectively, they are the “Parties.”
AMENDMENT 1 TO THE INHALED COLLABORATION AND OPTION AGREEMENTInhaled Collaboration and Option Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus
This Amendment no. 1 to the Agreement (“Amendment”) is made effective as of the 13th day of May 2015 (“Amendment Effective Date”) by and between:
ContractInhaled Collaboration and Option Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus
Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
MANUFACTURING DEVELOPMENT AND SCALE-UP AGREEMENTManufacturing Development and Scale-Up Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
This Manufacturing Development and Scale-up Agreement (the “Agreement”) is made as of March 19, 2012 (the “Effective Date”), between Liquidia Technologies, Inc., a Delaware corporation (“Liquidia”) having its principal place of business at Suite 100, 419 Davis Drive, Morrisville, NC 27560 and Chasm Technologies, Inc., a Massachusetts corporation (“Chasm”) with principal offices located at 85 Wagon Rd, Westwood, MA 02090.
LEASE AGREEMENTLease Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • North Carolina
The Plans and Specifications for the Additional Tenant Improvements shall be mutually approved by the parties (which approval shall not be unreasonably withheld, delayed, or conditioned). A copy of the approved Plans and Specifications for the Additional Tenant Improvements shall be initialed by each party and attached to this Lease subsequent to its execution by the parties. If, despite reasonable efforts, the parties are unable to agree on the Plans and Specifications within thirty (30) days after the Execution Date, either party may terminate this Lease by giving Landlord written notice of termination to the other.
6th AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus
6th AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT, (“6th Amendment”) effective as of June 10, 2016 (“Effective Date”), by and between The University of North Carolina at Chapel Hill, having an address at 100 Europa Drive, Suite 430, Chapel Hill, North Carolina 27517, (“University”), and Liquidia Technologies, Inc., a corporation existing under the laws of Delaware, and having an address at 419 Davis Drive, Suite 100, Morrisville, NC 27560 (“Licensee”).
NINTH AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus
This Ninth Amendment to Loan and Security Agreement (the “Amendment”) is made and entered into as of March 29, 2018 by and between PACIFIC WESTERN BANK, a California state chartered bank (“Bank”), and LIQUIDIA TECHNOLOGIES, INC. (“Borrower”).
INHALED COLLABORATION AND OPTION AGREEMENTInhaled Collaboration and Option Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
ContractManufacturing Development and Scale-Up Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
THIS DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”) is entered into as of June 8, 2016 (the “Effective Date”) by and between LIQUIDIA TECHNOLOGIES, INC., a Delaware corporation, having its principal place of business at 419 Davis Dr., Suite 100, Morrisville, NC 27560 (“Liquidia”), and G&W LABORATORIES, INC., a New Jersey corporation having its principal place of business at 111 Coolidge Street, South Plainfield, NJ 07080-3895 (“G&W”). Liquidia and G&W are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
AMENDMENT 1 TO THE DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
THIS AMENDMENT 1 TO THE DEVELOPMENT AND LICENSE AGREEMENT (the “1st Amendment”) is entered into as of November 8, 2016 (the “Effective Date”) by and between LIQUIDIA TECHNOLOGIES, INC., a Delaware corporation, having its principal place of business at 419 Davis Dr., Suite 100, Morrisville, NC 27560 (“Liquidia”), and G&W LABORATORIES, INC., a New Jersey corporation having its principal place of business at 111 Coolidge Street, South Plainfield, NJ 07080-3895 (“G&W”). Liquidia and G&W are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
ContractLicense Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus
Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • North Carolina
This LICENSE AGREEMENT is entered into as of December 15, 2008 and is hereby made effective as of December 15, 2008 (the “EFFECTIVE DATE”) by and between The University of North Carolina at Chapel Hill having an address at Campus Box 4105, 308 Bynum Hall, Chapel Hill, North Carolina, 27599-4105 (hereinafter referred to as “UNIVERSITY”) and Liquidia Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware having its principal office/place of business at 419 Davis Drive, Suite 100, Durham, NC 27713 (hereinafter referred to as “LICENSEE”).
